|
Model Number PCDG1 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Abdominal Pain (1685); Adhesion(s) (1695); Hemorrhage/Bleeding (1888); Inflammation (1932); Ischemia (1942); Hernia (2240); Obstruction/Occlusion (2422)
|
Event Type
Injury
|
Manufacturer Narrative
|
The batch number could be verified.Our manufacturing q-system assures, that production and process controls are in place to ensure that batches confirm to the applicable specifications before they are distributed. the non-integration of an endosseous dental implant during the healing phase is a known inherent risk of the treatment with dental implants.Most implant failures occur before occlusal loading (analainen et al.2009).Based on clinical studies about 1-3% of the implants fail within the first year after implantation (ganeles et al.2008).Implants may have to be removed in case one or more of the implant success criteria are not met.Implant success criteria according to buser et al.(1991) are: absence of persistent subjective complaints such as pain, foreign body sensation and /or dysesthesia, absence of a recurrent peri-implant infection with suppuration, absence of implant mobility, absence of a continuous radiolucency around the implant.The manufacturer's trend analysis confirms that the reported early failure rate associated with its dental implants is below the expected failure rate for this treatment as published in the scientific literature.
|
|
Event Description
|
It was reported by an attorney that the patient underwent hernia repair surgery on (b)(6) 2014 and mesh was implanted.It was reported that the patient underwent recurrent hernia repair surgery on (b)(6) 2017 during which the surgeon noted ¿he was forced to convert to an open exploratory laparotomy due to extensive adhesions and small bowel involvement with the previously placed mesh.The affected bowel was noted to be matted and hemorrhagic and to repair the bowel obstruction he was ultimately forced to remove approximately eleven inches of small bowel.¿ it was reported that the patient experienced dense adhesions, small bowel obstructions, acute and chronic inflammation, ischemic bowel, chronic and intractable abdominal pain.No additional information was provided.
|
|
Manufacturer Narrative
|
Date sent to the fda: 1/19/2022.A review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.
|
|
Search Alerts/Recalls
|
|
|